TenderDekho Logo
GEM

Tender Notice for CLONIDINE 100 MCG TAB,NETHYLPHENIDATE 10 MG TAB,BACLOFEN XL 30 MG TAB in SOUTH ANDAMAN, ANDAMAN & NICOBAR

Bid Publish Date

18-Jun-2025, 9:13 am

Bid End Date

26-Jul-2025, 12:00 pm

Progress

Issue18-Jun-2025, 9:13 am
Corrigendum22-Jul-2025
AwardPending
Explore all 4 tabs to view complete tender details

Quantity

1530

Category

CLONIDINE 100 MCG TAB

Bid Type

Single Packet Bid

Categories 2

Hqids announces a tender for CLONIDINE 100 MCG TAB, NETHYLPHENIDATE 10 MG TAB, BACLOFEN XL 30 MG TAB in SOUTH ANDAMAN, ANDAMAN & NICOBAR. Quantity: 1530. Submission Deadline: 26-07-2025 12: 00: 00. Last date to apply is approaching fast!

Documents 6

GeM-Bidding-7979494.pdf

Main Document

Other Documents

OTHER

Other Documents

OTHER

Other Documents

OTHER

Buyer uploaded ATC document

ATC

GEM General Terms and Conditions Document

GEM_GENERAL_TERMS_AND_CONDITIONS

Past Similar Tenders (Historical Results)

4 found

TAB RANITIDINE 150 MG,TAB BACLOFEN 5 MG,TAB SALBUTAMOL 4 MG,TAB PENTOXYFYLLINE 400 MG,TAB ALFUZOSIN

Indian Army

HYDERABAD, TELANGANA

Posted: 3 December 2025
Closed: 13 December 2025
GEM

TAB HYDROCHLOROTHIAZIDE 25 MG,CAP MEFENAMIC ACID 500 MG,TAB CLONIDINE 100 MCG,TAB ANTACID CHEWABLE

Indian Army

HYDERABAD, TELANGANA

Posted: 28 November 2025
Closed: 8 December 2025
GEM

TAB SACUBITRIL AND VALSARTAN (24MG+ 26MG),TAB IVABRADINE 5 MG,TAB CABOZANTINIB 60 MG,TAB OLMESARTAN

Hqids

SOUTH ANDAMAN, ANDAMAN & NICOBAR

Posted: 12 May 2025
Closed: 2 June 2025
GEM

Tab Eplerenone 25 mg,Tab Tofacitinib 5 mg,Tab Methotrexate 15 mg

Hqids

SOUTH ANDAMAN, ANDAMAN & NICOBAR

Posted: 7 January 2025
Closed: 28 January 2025
GEM

🤖 AI-Powered Bidder Prediction

Discover companies most likely to bid on this tender

Live AI
Historical Data

Required Documents

1

Experience Criteria

2

Past Performance

3

Bidder Turnover

4

Certificate (Requested in ATC)

5

OEM Annual Turnover

6

Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria

7

the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer

Corrigendum Updates

2 Updates
#1

Update

22-Jul-2025
#2

Update

12-Jul-2025

Frequently Asked Questions

Key insights about ANDAMAN & NICOBAR tender market

What are the eligibility requirements for GEM/2025/B/6355711?

The eligibility requirements include being a registered entity capable of supplying pharmaceutical products. Bidders must show proof of compliance with local regulations and have a track record of successful previous contracts in supplying medical supplies. Companies specializing in pharmaceuticals are encouraged to apply, particularly those with experience in military or governmental contracts.

What certificates are required for compliance with the GEM/2025/B/6355711 tender?

Bidders must provide relevant certificates, including GMP (Good Manufacturing Practices) certifications and any necessary pharmaceutical registration documentation. These certificates confirm that suppliers follow the highest standards in the production and handling of medications, ensuring safety and efficacy.

How do I submit documents for the GEM/2025/B/6355711 tender?

Documents for the tender must be submitted electronically through the designated bidding platform. The accepted formats include PDF and Microsoft Word. Bidders should ensure that all documents are correctly formatted and complete to prevent disqualification from the tendering process.

What is the Earnest Money Deposit (EMD) requirement for the GEM/2025/B/6355711 tender?

The Earnest Money Deposit (EMD) is a financial guarantee that bidders must submit alongside their bid. It serves as proof of earnestness in participating in the tender. Details regarding the amount and submission process are outlined in the tender documents, and non-compliance could result in bid rejection.

Are there any benefits for MSEs participating in the GEM/2025/B/6355711 tender?

Yes, the tender includes specific provisions aimed at benefiting Micro, Small, and Medium Enterprises (MSEs). These may involve relaxed eligibility criteria, additional preferences in the evaluation process, or support mechanisms aimed at enabling equal opportunities for MSE participation in government contracts.